| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.1M | -29.1% |
| Cost of Revenue | $20.9M | -21.7% |
| R&D Expense | $9.9M | +30.7% |
| SG&A Expense | $40.2M | -8.4% |
| Operating Income | -$13.7M | -559.8% |
| Pre-tax Income | -$14.6M | -302.3% |
| Income Tax | $61K | -72.4% |
| Net Income | -$14.7M | -280.8% |
| EPS (Basic) | -$0.72 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.3M | -26.0% |
| Accounts Receivable | $10.2M | -32.8% |
| Inventory | $14.4M | +41.4% |
| Current Assets | $48.2M | -14.7% |
| Total Assets | $80.2M | +4.4% |
| Current Liabilities | $35.2M | -16.0% |
| Long-term Debt | $24.9M | +70.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | -274.2% |
| Investing Cash Flow | -$15.0M | -200.0% |
| Financing Cash Flow | $17.0M | +453.7% |
| -242.9% |
| EPS (Diluted) | -$0.72 | -242.9% |
| Total Liabilities |
| $60.2M |
| +6.5% |
| Stockholders' Equity | $20.1M | -1.4% |